News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mehta Vimal
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 21,988 shares
@ $21.41, valued at
$470.8k
Sold 8,012 shares
@ $21.9, valued at
$175.5k
Sold 24,987 shares
@ $20.01, valued at
$500k
Sold 4,266 shares
@ $20.9, valued at
$89.2k
Sold 747 shares
@ $21.89, valued at
$16.4k
Exercised 2,609 restricted stock units
@ $0
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
|
|
| 05/24/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 6,500 shares
@ $25.7909, valued at
$167.6k
|
|
| 05/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 15,000 restricted stock units
@ $0 |
|
| 03/22/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 24,667 shares
@ $18.2, valued at
$448.9k
Sold 5,333 shares
@ $18.86, valued at
$100.6k
Sold 3,896 shares
@ $18.22, valued at
$71k
Sold 604 shares
@ $18.88, valued at
$11.4k
Sold 29,100 shares
@ $19.7, valued at
$573.3k
Sold 900 shares
@ $20.15, valued at
$18.1k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
|
|
| 03/16/2023 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 10,437 restricted stock units
@ $0
Granted 56,000 restricted stock units
@ $0
Granted 168,000 options to buy
@ $19.6, valued at
$3.3M
|
|
| 12/19/2022 |
4
| Mehta Vimal (CEO and President) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 22,794 shares
@ $19.86, valued at
$452.7k
Sold 7,206 shares
@ $20.19, valued at
$145.5k
Sold 20,113 shares
@ $19.21, valued at
$386.4k
Sold 9,887 shares
@ $19.92, valued at
$196.9k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
Exercised 30,000 options to buy
@ $0.41, valued at
$12.3k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 473,250 shares
@ $30.8283, valued at
$14.6M
|
|
| 03/29/2021 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $41.17, valued at
$10.3M
|
|
| 05/28/2020 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $45.99, valued at
$11.5M
|
|
| 05/13/2020 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Disposed/sold 300,000 shares
@ $30.08, valued at
$9M
|
|
| 08/19/2019 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 974 shares
@ $8.89, valued at
$8.7k
|
|
| 08/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2019 |
4
| Mehta Vimal (CEO, President and Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 187,700 options to buy
@ $10.04, valued at
$1.9M
|
|
| 12/14/2018 |
4
| Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 800 shares
@ $4.27, valued at
$3.4k
Bought 200 shares
@ $4.32, valued at
$864
Bought 500 shares
@ $4.48, valued at
$2.2k
Bought 400 shares
@ $4.49, valued at
$1.8k
Bought 100 shares
@ $4.5, valued at
$450 |
|
| 12/04/2018 |
4
| Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $5.09, valued at
$2.5k
Bought 500 shares
@ $5.15, valued at
$2.6k
|
|
| 12/04/2018 |
4
| Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $5.1, valued at
$1k
Bought 100 shares
@ $5.13, valued at
$513
Bought 100 shares
@ $5.14, valued at
$514
Bought 100 shares
@ $5.18, valued at
$518
Bought 500 shares
@ $5.2, valued at
$2.6k
|
|
| 11/30/2018 |
4
| Mehta Vimal (CEO, President, Secretary) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 300 shares
@ $5.04, valued at
$1.5k
Bought 300 shares
@ $5.05, valued at
$1.5k
Bought 100 shares
@ $5.17, valued at
$517
Bought 300 shares
@ $5.2, valued at
$1.6k
|
|
|
|